- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Need to Raise Resident Awareness on Care Costs, Study Concludes
A survey of about 18,000 residents training in internal medicine found that nearly three-fourths were unaware of the costs of the treatment that they prescribe for patients or the tests that they order.
A survey of about 18,000 residents training in internal medicine in the United States found that nearly three-fourths were unaware of the costs of the treatment that they prescribe for patients or the tests that they order.
The study was designed by the American College of Physicians and the Alliance for Academic Internal Medicine was designed to understand the knowledge of, attitude toward, and self-reported practice of High Value Care that balances the cost of care with benefits and harms among internal medicine residents.
A co-author on the study, which was published in the Academic Medicine: The Journal of the Association of American Medical Colleges, said she was surprised with the small number of residents who were aware of the costs of treatments and diagnostic tests and incoporated them into their clinical decisions.
These results have prompted the American College of Physicians to design a new curriculum that would train physicians to include costs and patient treatment goals in their clinical decisions.
Read more on MedpageToday.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Functional Similarity Between Ustekinumab Biosimilar ABP 654, Stelara in Crohn Disease
March 10th 2025Functional similarity of the ustekinumab biosimilar ABP 654 (Wezlana) and the reference product (Stelara) was confirmed by a series of in vitro studies, which support the totality of evidence for the biosimilar's FDA approval.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
